Candriam Luxembourg S.C.A.
Q4 2020 13F-HR Holdings
Net value change ($000)
+1,991,432
(18.7%)
New positions
79
Sold out positions
70
Turnover %
7.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AAPL | 194,347 | 83.8% |
| Seagen Inc. | 89,788 | NEW |
| C | 66,303 | 290.0% |
| CRM | 57,913 | 2959.3% |
| MRK | 55,733 | 22.9% |
| GOOGL | 52,881 | 20.8% |
| TSLA | 43,486 | 65.8% |
| MRNA | 41,387 | NEW |
| TSM | 40,044 | 54.8% |
| Turning Point Therapeutics, Inc. | 35,138 | 171.0% |
Top Reduces (Value $000, Stocks/ETFs)
| Seagen Inc. | -101,187 | -100.0% |
| AMZN | -69,528 | -28.5% |
| Vivint Solar, Inc. | -35,612 | -100.0% |
| BABA | -32,238 | -24.4% |
| Advanced Disposal Services, Inc. | -31,672 | -100.0% |
| DG | -23,476 | -63.1% |
| TD AMERITRADE HOLDING CORP | -23,112 | -100.0% |
| GRIZZLY MERGER SUB 1, LLC | -22,513 | -100.0% |
| MyoKardia, Inc. | -21,263 | -100.0% |
| META | -18,822 | -13.2% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,533
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|